Bits of life, drop by drop

Bits of life, drop by drop
Credit: Hamad M

(PhysOrg.com) -- Swiss scientists are working on creating artificial living tissues using a very special kind of inkjet printer. Still in its initial stages, this technology could nonetheless soon provide biological samples that could be used for testing new drugs.

An important step toward creating artificial living material has been made by EPFL researchers. They are working on a technique that should eventually allow them to “print” living constructs resembling human tissues in which can develop and interact in a coordinated and physiological manner. Their research results have recently been published in the scientific journal Advanced Materials.

“We have not yet created tissue, strictly speaking,” explains Professor Jürgen Brügger, head of EPFL’s Microsystems 1 Laboratory. “At this stage, we have essentially studied a way in which to structure biological materials in three dimensions; this research will improve cell culture and then will eventually be used as a base for creating tissues.”

Someday this new technology, which is the fruit of joint research between EPFL’s Engineering School (STI) and School of Life Sciences (SV), will make it possible to print tissues one drop at a time. Progress made in several different areas has combined to bring the technology to this point.

First, printing involves ink, a raw material that’s challenging to design, explains Professor Matthias Lutolf, head of EPFL’s Stem Cell Engineering Laboratory. “Mixing the right ingredients isn’t sufficient. The cells grow in a haphazard manner, randomly, and won’t develop into viable tissue.”

A more malleable material

To make up a coherent whole, the cells need an environment that provides the right kinds of signals that induce very specific behavior in each of the cells – proliferation, migration, differentiation or death. In natural tissues, these signals come from molecules that make up a complex extracellular matrix (ECM). By studying the connections and communications taking place between cells and between cells and ECM molecules, the scientists were able to reconstruct this matrix and thus create a new kind of biological ink.

On a technical level, the researchers from EPFL’s two Microsystems Laboratories – under the leadership of professors Jürgen Brugger and Philippe Renaud – focused on developing a gel that could be used as a base from which the tissue could be constructed, as well as a strategy for printing droplets. Thanks to the gel, made up of concentrated calcium, and the printing sequence they came up with, each droplet of ink landing on the surface sticks to it and keeps its initial shape instead of spreading out.

“The various tissue elements don’t blend together uncontrollably,” explains Brugger. “Above all, the material polymerizes more quickly and becomes flexible and malleable, which allows us to assemble several layers and to envision building channels, which are indispensable for fluid perfusion, nutrient input and waste elimination.”

Testing new drugs

“Thanks to the combination of these technical and biological advances, we are working towards the growth of a tissue in which the cells develop and live happily,” Lutolf explains.

Even though it will still be quite some time before can be constructed, this technology could lead to very promising applications on the medium term. “ An exiting avenue would be to develop 3D constructs that function like human tissues and could be used as models for testing ,” says Lutolf. “This is not only very interesting in a biological sense, but could also reduce the need for animal testing.”


Explore further

Development of 'matrix' material controlling differentiation of stem cells

Provided by Ecole Polytechnique Federale de Lausanne
Citation: Bits of life, drop by drop (2012, January 16) retrieved 23 October 2019 from https://phys.org/news/2012-01-bits-life.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Jan 16, 2012
at the current stage of understanding of the complexity of cell/cell and cell/ECM interactions, our knowledge is insufficient to mimic the functions of even the simplest ECMs in the body.. Thus, I am quite skeptical that they will be able to get valid "in-vivo-like" results from the drug-testing experiments they envision.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more